Multiple myeloma (MM) is an incurable plasma cell malignancy, which is predominantly a
disease of older adults (the median age at diagnosis is 70 years). The slow progression from …

Simple Summary Choosing the optimal therapy for elderly patients with multiple myeloma
(MM) poses a difficult challenge for clinicians. Older patients are an extremely …

Multiple myeloma is a plasma cell malignancy that occurs among older adults and accounts
for 15% of all hematologic malignancies in the United States. Thirty-five percent of patients …

Few studies have been performed regarding multiple myeloma (MM) in elderly patients. We
report a retrospective series of 130 unselected patients with MM aged 75 yr or more at …

Abstract Purpose of Review Approximately one half of the patient-population in multiple
myeloma (MM) is> 70 years at diagnosis. Despite notable strides in the management and …

Introduction: Multiple myeloma is a disease predominately affecting older adults. Pivotal to
treating older adults is understanding their physiologic differences compared to younger …

Abstract Purpose of Review Given the median age at diagnosis of 69, multiple myeloma
(MM) is commonly identified among elderly individuals. Over-treatment of the frail may lead …

While multiple myeloma is an incurable disease for nearly all patients, current chemotherapy
and supportive care can result in significant disease control and improved duration of …

Purpose Multiple myeloma (MM) is disproportionately diagnosed in older adults; with the
aging of the population, the number of older adults diagnosed with MM will increase by …

Multiple myeloma (MM) in patients aged greater than 80 years poses an increasingly
common challenge for oncology providers. A multidisciplinary workshop was held in which …